OTCMKTS:SEOVF

Sernova Stock Forecast, Price & News

$0.92

+0.02 (+1.76%)

(As of 06/27/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.87
▼
$0.93
50-Day Range: $0.78
▼
$1.23
52-Week Range: $0.73
▼
$1.76

Volume: 30,016 shs
Average Volume: 41,203 shs
Market Capitalization: $252.42 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive SEOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

SEOVF Stock Forecast (MarketRank)

Overall MarketRank^™

0.96 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Sernova.

4.8 Community Rank

Outperform Votes
Sernova has received 52 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Sernova has received 21 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Sernova has received 71.23% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote “Outperform” if you believe SEOVF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SEOVF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Sernova does not currently pay a dividend.
Dividend Growth
Sernova does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sernova insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.01% of the stock of Sernova is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Sernova is -18.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sernova is -18.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Sernova has a P/B Ratio of 10.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Sernova (OTCMKTS:SEOVF)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

SEOVF Stock News Headlines

June 7, 2022 | apnews.com

Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022

May 17, 2022 | seekingalpha.com

Evotec teams up with Sernova to develop diabetes therapy, commits €20M equity investment

May 17, 2022 | finance.yahoo.com

Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes

January 5, 2022 | uk.finance.yahoo.com

Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare Conference

June 29, 2021 | finance.yahoo.com

Here's Why We're Not At All Concerned With Sernova's (CVE:SVA) Cash Burn Situation

February 5, 2021 | finance.yahoo.com

BTV News Alert Video: Sernova Corp. - A Functional Cure for Type I Diabetes

February 3, 2021 | benzinga.com

Sernova Corp. Announces C$10 Million Bought Deal Offering of Units

January 21, 2021 | theglobeandmail.com

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated

January 15, 2021 | finance.yahoo.com

IIROC Trading Resumption - SVA

August 28, 2020 | finance.yahoo.com

Bill Ackman Is Back in the Spotlight. Here’s an Overlooked Way to Invest in His Success.

August 17, 2020 | ca.finance.yahoo.com

Sernova Corp. (SEOVF)

June 8, 2020 | seekingalpha.com

Sernova to acquire cellular local immune protection technology

May 22, 2020 | finance.yahoo.com

Does The Sernova Corp. (CVE:SVA) Share Price Tend To Follow The Market?

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SEOVF
CUSIP: N/A
CIK: 1491434
Web: www.sernova.com
Phone: (519) 858-5184
Fax: 519-858-5184
Employees: N/A
Year Founded: N/A

Company Calendar

Today: 6/28/2022
Fiscal Year End: 10/31/2022

Profitability

EPS (Most Recent Fiscal Year): ($0.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5.54 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -36.34%
Return on Assets: -34.73%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 19.19
Quick Ratio: 19.19

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.09 per share
Price / Book: 10.18

Miscellaneous

Outstanding Shares: 275,630,000
Free Float: N/A
Market Cap: $252.42 million
Optionable: Not Optionable
Beta: 1.17

Sernova Frequently Asked Questions

How has Sernova's stock price performed in 2022?: Sernova's stock was trading at $1.45 at the beginning of 2022. Since then, SEOVF stock has decreased by 36.8% and is now trading at $0.9158.
View the best growth stocks for 2022 here.
Who are Sernova's key executives?: Sernova's management team includes the following people:
Mr. Frank A. Holler MBA, Exec. Chairman (Age 65, Pay $51.51k)
Dr. Philip M. Toleikis B.A., M.Sc., Ph.D., Pres, CEO & Director
Mr. David Swetlow C.A, C.A., CPA, Chief Financial Officer
Mr. Douglas Maret, Chief Science Officer
Mr. Christopher Barnes, VP of Investor Relations
Who are some of Sernova's key competitors?: Some companies that are related to Sernova include Chinook Therapeutics (KDNY), Procaps Group (PROC), Avid Bioservices (CDMO), BELLUS Health (BLU), MannKind (MNKD), ImmunoGen (IMGN), Aclaris Therapeutics (ACRS), Crinetics Pharmaceuticals (CRNX), Veru (VERU), Merus (MRUS), I-Mab (IMAB), Enanta Pharmaceuticals (ENTA), Deciphera Pharmaceuticals (DCPH), uniQure (QURE) and Rocket Pharmaceuticals (RCKT).
View all of SEOVF's competitors.

What is Sernova's stock symbol?: Sernova trades on the OTCMKTS under the ticker symbol "SEOVF."
How do I buy shares of Sernova?: Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sernova's stock price today?: One share of SEOVF stock can currently be purchased for approximately $0.92.
How much money does Sernova make?: Sernova (OTCMKTS:SEOVF) has a market capitalization of $252.42 million. The company earns $-5.54 million in net income (profit) each year or ($0.05) on an earnings per share basis.
How can I contact Sernova?: Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The official website for Sernova is www.sernova.com. The company can be reached via phone at (519) 858-5184, via email at [email protected], or via fax at 519-858-5184.

This page (OTCMKTS:SEOVF) was last updated on 6/28/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources